To evaluate the safety and efficacy of the oral dose of YM150 for prevention of venous thromboembolism (VTE) in patients with acute medical illness.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
52
oral
Unnamed facility
Chugoku, Japan
Unnamed facility
Chūbu, Japan
Unnamed facility
Kansai, Japan
Unnamed facility
Kantou, Japan
Unnamed facility
Tōhoku, Japan
Composite assessment of VTE events and all cause death
Time frame: Until day 28
Incidence of bleeding events
Time frame: Until day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.